What is the ROE (Return on Equity) of Equasens this year?
The ROE of Equasens this year is 0.21 undefined.
Equasens ROE 2024
Equasens ROE
0.21
Ticker
EQS.PA
ISIN
FR0012882389
WKN
A14XZH
In 2024, Equasens's return on equity (ROE) was 0.21, a -12.24% increase from the 0.24 ROE in the previous year.
Equasens Aktienanalyse
What does Equasens do?
Pharmagest Interactive SA is a leading provider of digital solutions for pharmacies and healthcare providers. The company was founded in France in 1986 and is headquartered in Villers-lès-Nancy. The company offers a wide range of software solutions for healthcare providers and pharmacies. Its main business areas include pharmacy management systems, healthcare management solutions, and telemedicine solutions. Pharmagest Interactive SA's pharmacy management systems include software solutions for inventory management, prescription management, and billing. The company also provides e-learning courses and training for pharmacies. Its healthcare management solutions focus on patient data management, with features such as patient records, appointment scheduling, and prescription management. These solutions are used by healthcare providers to optimize patient data management and improve patient care. Pharmagest Interactive SA also offers telemedicine solutions, including remote visit applications, online consultations, and teleconsultations. These solutions are particularly useful for patients in rural areas or with limited mobility. The company's products and services include Crossway, a pharmacy management software; LGPI, a patient management software for hospitals and healthcare providers; Noviatek, a digital prescription management system; and Monolog, a cloud-based platform for telemedicine services. In summary, Pharmagest Interactive SA provides a variety of digital solutions for pharmacies and healthcare providers, focusing on optimizing patient data management, inventory management, and billing. The company is also a pioneer in telemedicine solutions. Equasens ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Equasens's Return on Equity (ROE)
Equasens's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Equasens's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Equasens's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Equasens’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Equasens stock
How has the Return on Equity (ROE) of Equasens developed compared to the previous year?
The ROE of Equasens has increased by -12.24% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Equasens?
A high ROE indicates that Equasens generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Equasens?
A low ROE can indicate that Equasens is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Equasens affect the company?
A change in ROE (Return on Equity) of Equasens can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Equasens?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Equasens?
Some factors that can influence Equasens's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Equasens pay?
Over the past 12 months, Equasens paid a dividend of 1.15 EUR . This corresponds to a dividend yield of about 2.63 %. For the coming 12 months, Equasens is expected to pay a dividend of 1.33 EUR.
What is the dividend yield of Equasens?
The current dividend yield of Equasens is 2.63 %.
When does Equasens pay dividends?
Equasens pays a quarterly dividend. This is distributed in the months of August, July, August, August.
How secure is the dividend of Equasens?
Equasens paid dividends every year for the past 0 years.
What is the dividend of Equasens?
For the upcoming 12 months, dividends amounting to 1.33 EUR are expected. This corresponds to a dividend yield of 3.03 %.
In which sector is Equasens located?
Equasens is assigned to the 'Health' sector.
Wann musste ich die Aktien von Equasens kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Equasens from 7/4/2024 amounting to 1.25 EUR, you needed to have the stock in your portfolio before the ex-date on 7/2/2024.
When did Equasens pay the last dividend?
The last dividend was paid out on 7/4/2024.
What was the dividend of Equasens in the year 2023?
In the year 2023, Equasens distributed 1.05 EUR as dividends.
In which currency does Equasens pay out the dividend?
The dividends of Equasens are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Equasens stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Equasens
Our stock analysis for Equasens Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Equasens Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.